ASCEPLUS

Pharmaceutical agents affecting peripheral nervous system; veterinary substances, namely, veterinary substances used for wound healing, skin disorder treatment and inflammatory disease treatment; veterinary preparations for the treatment of wounds, skin disorders and inflammatory diseases; stem cells for veterinary purposes; ophthalmic preparations; cells for medical purposes; reagents for medical use; drugs for medical purposes for the treatment of wounds, skin disorders and inflammatory diseases; stem cells for medical purposes; skin anti-aging preparations for medical use; medicinal preparations for stimulating hair growth; pharmaceutical skin lotions; pharmaceutical compositions for the treatment of wounds, skin disorders and inflammatory diseases; pharmaceuticals for the treatment of wounds, skin disorders and inflammatory diseases; transplants, namely, implants comprising living tissue; human allograft tissue; biological biomaterials for tissue restoration, namely, biological cell extracts for medical purposes, biological cell culture extracts for medical purposes; injectable dermal fillers; implantable medicines, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating wounds, skin disorders and inflammatory diseases; surgical implants comprising living tissue grown from stem cells; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical preparations for skin whitening; pharmaceutical preparations for skin moisturizing; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for skin regeneration

Medical apparatus for injecting fillers, namely, injection needles, injection syringes, jet injectors for medical use; artificial skin for surgical purposes; artificial implants for skin regeneration